DK1361216T3 - Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor - Google Patents

Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor

Info

Publication number
DK1361216T3
DK1361216T3 DK03013275T DK03013275T DK1361216T3 DK 1361216 T3 DK1361216 T3 DK 1361216T3 DK 03013275 T DK03013275 T DK 03013275T DK 03013275 T DK03013275 T DK 03013275T DK 1361216 T3 DK1361216 T3 DK 1361216T3
Authority
DK
Denmark
Prior art keywords
preparing
protease inhibitor
hiv protease
hiv
inhibitor
Prior art date
Application number
DK03013275T
Other languages
Danish (da)
English (en)
Inventor
Kathleen R Whitten
Michael E Deason
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Application granted granted Critical
Publication of DK1361216T3 publication Critical patent/DK1361216T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/08Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/28Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/287Preparation of carboxylic acid esters by modifying the hydroxylic moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12Acetic acid esters
    • C07C69/14Acetic acid esters of monohydroxylic compounds
    • C07C69/145Acetic acid esters of monohydroxylic compounds of unsaturated alcohols
    • C07C69/157Acetic acid esters of monohydroxylic compounds of unsaturated alcohols containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03013275T 1996-09-05 1997-09-04 Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor DK1361216T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70841196A 1996-09-05 1996-09-05

Publications (1)

Publication Number Publication Date
DK1361216T3 true DK1361216T3 (da) 2006-01-23

Family

ID=24845703

Family Applications (2)

Application Number Title Priority Date Filing Date
DK03013275T DK1361216T3 (da) 1996-09-05 1997-09-04 Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor
DK97941402T DK0927165T3 (da) 1996-09-05 1997-09-04 Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK97941402T DK0927165T3 (da) 1996-09-05 1997-09-04 Mellemprodukter til fremstilling af HIV-protease inhibitorer og fremgangsmåde til fremstilling af HIV-protease inhibitorer

Country Status (33)

Country Link
EP (2) EP1361216B1 (uk)
JP (3) JP4149000B2 (uk)
KR (1) KR100563289B1 (uk)
CN (2) CN1183117C (uk)
AP (2) AP1322A (uk)
AT (2) ATE254603T1 (uk)
AU (2) AU740369B2 (uk)
BG (2) BG64793B1 (uk)
BR (1) BR9713192A (uk)
CA (1) CA2264756A1 (uk)
CZ (2) CZ298175B6 (uk)
DE (2) DE69734689T2 (uk)
DK (2) DK1361216T3 (uk)
EA (1) EA002051B1 (uk)
EE (1) EE04465B1 (uk)
ES (2) ES2210573T3 (uk)
GE (1) GEP20022799B (uk)
HK (1) HK1062171A1 (uk)
HU (1) HUP0000028A3 (uk)
IL (1) IL128567A (uk)
IS (1) IS2030B (uk)
NO (1) NO313287B1 (uk)
NZ (1) NZ334909A (uk)
OA (1) OA10988A (uk)
PL (2) PL198408B1 (uk)
PT (1) PT927165E (uk)
SG (1) SG94780A1 (uk)
SI (2) SI0927165T1 (uk)
SK (2) SK284899B6 (uk)
TR (1) TR199900473T2 (uk)
UA (1) UA67727C2 (uk)
WO (1) WO1998009951A2 (uk)
YU (1) YU11599A (uk)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors
JPH07248183A (ja) * 1994-03-11 1995-09-26 Osaka Gas Co Ltd 浴室兼用衣類乾燥室
JP3298293B2 (ja) * 1994-03-14 2002-07-02 松下電器産業株式会社 厨芥処理機
AU4953796A (en) * 1995-03-15 1996-10-02 Sanyko Company, Limited Dipeptide compounds having ahpba structure
EP0983999B8 (en) * 1995-09-26 2005-06-08 Japan Tobacco Inc. Process for producing amide derivatives and intermediates
WO1997011938A1 (fr) * 1995-09-26 1997-04-03 Japan Tobacco Inc. Procede de production de derives amides et de leurs intermediaires
US5962704A (en) * 1995-09-26 1999-10-05 Japan Tobacco Inc. Production of amide derivatives and intermediate compounds therefor
CZ230398A3 (cs) * 1996-02-24 1999-01-13 Basf Aktiengesellschaft Derivát pyrazol-4-ylhetaroylu, způsob jeho přípravy a herbicidní prostředek, který ho obsahuje

Also Published As

Publication number Publication date
CZ71699A3 (cs) 1999-06-16
ATE254603T1 (de) 2003-12-15
TR199900473T2 (xx) 1999-06-21
SI0927165T1 (en) 2004-04-30
PL198408B1 (pl) 2008-06-30
CN1537846A (zh) 2004-10-20
PL331801A1 (en) 1999-08-02
UA67727C2 (uk) 2004-07-15
PL201758B1 (pl) 2009-05-29
BG65237B1 (bg) 2007-09-28
NZ334909A (en) 2000-06-23
CZ298175B6 (cs) 2007-07-11
WO1998009951A2 (en) 1998-03-12
AP9901497A0 (en) 1999-06-30
EE04465B1 (et) 2005-04-15
SK28299A3 (en) 1999-11-08
ES2252586T3 (es) 2006-05-16
EA002051B1 (ru) 2001-12-24
PT927165E (pt) 2004-04-30
SK284899B6 (sk) 2006-02-02
HUP0000028A3 (en) 2003-05-28
EA199900257A1 (ru) 1999-08-26
SI1361216T1 (sl) 2006-02-28
JP2001500495A (ja) 2001-01-16
EP0927165A2 (en) 1999-07-07
KR20010029489A (ko) 2001-04-06
CN1232455A (zh) 1999-10-20
DE69726298T2 (de) 2004-05-27
IS2030B (is) 2005-08-15
DE69726298D1 (de) 2003-12-24
CN1183117C (zh) 2005-01-05
AU766155B2 (en) 2003-10-09
EP1361216A1 (en) 2003-11-12
AU740369B2 (en) 2001-11-01
OA10988A (en) 2001-11-01
AP2003002938A0 (en) 2003-12-31
EP0927165B1 (en) 2003-11-19
SK285278B6 (sk) 2006-10-05
YU11599A (sh) 2000-03-21
DK0927165T3 (da) 2004-03-15
GEP20022799B (en) 2002-09-25
AP1322A (en) 2004-11-04
NO991072D0 (no) 1999-03-04
KR100563289B1 (ko) 2006-03-22
CA2264756A1 (en) 1998-03-12
IL128567A (en) 2004-03-28
AU1473602A (en) 2002-03-14
JP4149000B2 (ja) 2008-09-10
NO313287B1 (no) 2002-09-09
BG64793B1 (bg) 2006-04-28
NO991072L (no) 1999-03-04
BG103305A (en) 2000-01-31
CN1305854C (zh) 2007-03-21
EP1361216B1 (en) 2005-11-16
WO1998009951A3 (en) 1998-07-09
SG94780A1 (en) 2003-03-18
AU4331797A (en) 1998-03-26
IL128567A0 (en) 2000-01-31
ES2210573T3 (es) 2004-07-01
EE9900109A (et) 1999-12-15
HUP0000028A2 (hu) 2000-05-28
DE69734689D1 (de) 2005-12-22
IS4982A (is) 1999-02-19
CZ298174B6 (cs) 2007-07-11
ATE309990T1 (de) 2005-12-15
JP2008056693A (ja) 2008-03-13
JP2008088178A (ja) 2008-04-17
BR9713192A (pt) 1999-12-21
HK1062171A1 (en) 2004-10-21
DE69734689T2 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
BR9407782A (pt) Inibidores de protease do HIV
DK0812845T3 (da) Fremgangsmåde til fremstilling af sildenafil
PT936912E (pt) Inibidores de cisteina protease
DK0790226T3 (da) Fremgangsmåde til fremstilling af methanol
DK1142485T3 (da) Fremgangsmåde til forbedring af oplöseligheden af planteproteiner
DK0885968T3 (da) Fremgangsmåde til fremstilling af vanillin
DK0819704T3 (da) Fremgangsmåde til fremstilling af vandoplöselige polymerer
DK0911416T3 (da) Fremgangsmåde til fremstilling af protein
DK0937055T3 (da) Fremgangsmåde til fremstilling af d,I-alfa-tocopherol
DK0996642T3 (da) Fremgangsmåde til fremstilling af heparin
DK0912603T3 (da) Fremgangsmåde til fremstilling af visse azacyclohexapeptider
DK0970939T3 (da) Fremgangsmåde til fremstilling af methanol
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
EE200000568A (et) HIV-proteaasi inhibiitorite valmistamismeetod
DK0978502T3 (da) Fremgangsmåde til omestering af alfa-ketocarboxylsyrer
DK1023279T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK33696A (da) Fremgangsmåde til fremstilling af en LC-kreds
DK1361216T3 (da) Fremgangsmåde til fremstilling af en HIV-proteaseinhibitor
DK0923565T3 (da) Fremgangsmåde til fremstilling af paclitaxel
DK1015442T3 (da) Fremgangsmåde til fremstilling af 3-isochromanon
DK0882035T3 (da) Fremgangsmåde til fremstilling af 2H-1-benzopyraner
NO994415D0 (no) HIV proteaseinhibitorer
DK1295869T3 (da) Forbindelser og fremgangsmåde til fremstilling af substituerede 4-phenyl-4-cyanocyclohexansyrer
DK15693A (da) Fremgangsmåde til stabilisering af affald